ZA934536B - Angiotensin IV peptides and receptors - Google Patents
Angiotensin IV peptides and receptorsInfo
- Publication number
- ZA934536B ZA934536B ZA934536A ZA934536A ZA934536B ZA 934536 B ZA934536 B ZA 934536B ZA 934536 A ZA934536 A ZA 934536A ZA 934536 A ZA934536 A ZA 934536A ZA 934536 B ZA934536 B ZA 934536B
- Authority
- ZA
- South Africa
- Prior art keywords
- angiotensin
- receptors
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90639692A | 1992-06-24 | 1992-06-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA934536B true ZA934536B (en) | 1994-02-03 |
Family
ID=25422377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA934536A ZA934536B (en) | 1992-06-24 | 1993-06-24 | Angiotensin IV peptides and receptors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0647239A4 (xx) |
AU (1) | AU4649293A (xx) |
CA (1) | CA2139105A1 (xx) |
WO (1) | WO1994000492A1 (xx) |
ZA (1) | ZA934536B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6317996A (en) * | 1995-07-07 | 1997-02-10 | Sagami Chemical Research Center | Peptide derivatives and angiotensin iv receptor agonist |
US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
AU6861796A (en) * | 1995-10-30 | 1997-05-22 | Brigham And Women's Hospital | Angiotensin iv and analogs as regulators of fibrinolysis |
CA2242571C (en) * | 1996-08-06 | 2006-05-16 | Taisho Pharmaceutical Co., Ltd. | Amino compounds and angiotensin iv receptor agonists |
DE19825494A1 (de) * | 1998-06-08 | 1999-12-09 | Hoechst Marion Roussel De Gmbh | Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben |
JP2002522505A (ja) * | 1998-08-13 | 2002-07-23 | ユニヴァースティ オブ サザーン カリフォルニア | 虚血組織への血流を増加させる方法 |
AU2001233064A1 (en) * | 2000-01-27 | 2001-08-07 | University Of Southern California | Methods for inhibiting smooth muscle cell proliferation |
JP2005508882A (ja) | 2001-08-02 | 2005-04-07 | ホワード フローリー インスティチュート オブ エクスペリメンタル フィジオロジー アンド メディシン | インスリン調節アミノペプチダーゼ(irap)/アンギオテンシンiv(at4)受容体活性の調節 |
WO2008005531A2 (en) | 2006-07-07 | 2008-01-10 | Washington State University Research Foundation | C-met receptor regulation by angiotensin iv (at4) receptor ligands |
US8236761B2 (en) | 2006-07-07 | 2012-08-07 | Washington State University Research Foundation | C-Met receptor regulation by angiotensin IV (AT4) receptor ligands |
CN109563144B (zh) | 2016-06-01 | 2023-03-28 | 雅斯娜 | 化合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0445606B1 (en) * | 1990-02-27 | 1997-01-22 | The Agency of Industrial Science and Technology | Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
-
1993
- 1993-06-24 WO PCT/US1993/006038 patent/WO1994000492A1/en not_active Application Discontinuation
- 1993-06-24 ZA ZA934536A patent/ZA934536B/xx unknown
- 1993-06-24 CA CA002139105A patent/CA2139105A1/en not_active Abandoned
- 1993-06-24 AU AU46492/93A patent/AU4649293A/en not_active Abandoned
- 1993-06-24 EP EP93916733A patent/EP0647239A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2139105A1 (en) | 1994-01-06 |
EP0647239A4 (en) | 1997-07-02 |
AU4649293A (en) | 1994-01-24 |
WO1994000492A1 (en) | 1994-01-06 |
EP0647239A1 (en) | 1995-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL105877A0 (en) | Angiotensin ii antagonists | |
GB2269176B (en) | Peptides | |
GB9317760D0 (en) | Angiotensin ii antagonist | |
HU9502041D0 (en) | New peptide | |
GB9317758D0 (en) | Angiotensin ii antagonist | |
ZA934536B (en) | Angiotensin IV peptides and receptors | |
GB9500601D0 (en) | Modified peptides | |
IL117615A0 (en) | New peptides with immunomodulatory effects | |
GB9325519D0 (en) | Peptides | |
EP0838471A4 (en) | PEPTIDE DERIVATIVES AND AGONISTS OF THE ANGIOTENSIN IV RECEPTOR | |
GB9318901D0 (en) | Multiple branch peptide construction | |
IL116658A0 (en) | Peptides their preparation and use | |
GB9714276D0 (en) | Peptides and related compounds | |
GB9425380D0 (en) | Peptides | |
IL106436A0 (en) | Synthetic polypeptides and their use | |
GB9519511D0 (en) | Peptides | |
IL120336A0 (en) | Angiotensin II antagonists | |
GB9425381D0 (en) | Peptides | |
HU9300302D0 (en) | Cdns-s coding gastrine and cck-b receptors | |
AU292P (en) | WARRIGAL Glycine max | |
GB9226074D0 (en) | Peptide | |
GB9210074D0 (en) | Peptides | |
ZA935126B (en) | Peptides | |
EP0873349A4 (en) | TYPE III POLYPEPTIDE ACTIVATOR OF MONOCYTES AND ENDOTHELIAL CELLS | |
GB9519218D0 (en) | Peptide factor |